ArticleMicrobial cell factories2026
Site-directed mutagenesis and semi-rational design to enhance chitinolytic activity of bacterial exochitinase.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chitin, a prevalent biopolymer found in arthropod exoskeletons and fungal cell walls, requires efficient depolymerization to provide bioactive derivatives suitable for agriculture, medicine, and wastewater treatment. Bacterial chitinases, such as the exochitinases produced by Paenibacillus barengoltzii, are potential biocatalysts for chitin recycling; however, they exhibit insufficient activity and stability for industrial use. In this study, Semi-rational engineering and site-directed mutagenesis were employed to enhance catalytic efficiency, resulting in five mutants: M1 (D344Y), M2 (D192Y), M3 (D144Y), M4 (D534G), and M5 (D192A). M3 and M5 significantly increased chitinolytic activity, boosting it by 338% and 276%, respectively, compared to the original enzyme. Further enhancement was achieved by incorporating a chitin-binding domain (CBD), resulting in a six-fold increase in activity with the M35-CBD chimaera. Molecular dynamics (MD) simulations were performed on wild-type, M3, and M5 variations to elucidate the structural basis for these enhancements. M3 (D144Y) exhibited greater structural stability, less RMSD fluctuations, and an improved hydrogen bond network in the substrate-binding region. Notably, enhanced π-stacking interactions facilitated by solvent-exposed aromatic residues, including tryptophan, improved substrate affinity. Unlike the wild-type enzyme, the produced mutants exhibited reduced conformational mobility alongside increased substrate interaction. The results demonstrate the efficacy of targeted mutagenesis and domain engineering in creating stable chitinases for industrial and environmental biotechnology applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.